Senseonics Reports 140% Revenue Growth in Q3 and Sets 2026 Revenue Targets
Senseonics (SENS) reported a breakout third quarter, with revenue reaching $19.6 million. This represents a significant year-over-year increase of approximately 140%, more than doubling the company's performance from the previous year. Management noted that current sales trajectories are exceeding earlier internal expectations. Looking ahead, the company has established a long-term revenue target of $68 million to $70 million for 2026. This growth strategy is supported by the commencement of human testing for its Freedom CGM (Continuous Glucose Monitoring) system, marking a critical milestone in its product development pipeline.
Tickers: $SENS